In contrast, IBD LPMC are resistant to the TGF-β1-mediated immune suppression, as evidenced by no change in NF-kB activation and production of inflammatory cytokines following stimulation with recombinant TGF-β1 [26]. Here, TGFB1 is linked to inflammatory bowel disease.